30 completed, 10 unknown, 6 terminated, 4 not yet recruiting. 14 Phase 4, 12 Phase 2, 9 Not applicable, 8 Phase 3, 5 Phase 1.
Follow Ceftazidime: new trials by email Literature Review of Ceftazidime trials Research Report on Ceftazidime
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Restrictive Versus Standard Antibiotic Treatment During CAR-T Therapy ceftazidime, ciprofloxacin, Standard-of-Care Antibiotic Strategy - Large B-Cell Lymphoma (LBCL), Multiple Myeloma (MM) | Phase 2 | Not yet recruiting | Zealand University Hospital | 150 | 2027-03-01 | 2026-09-25 |
| Early Optimization of Ceftazidime Regimen in Critical Care ceftazidime, plasma ceftazidime dosage - Infection in ICU, Sepsis | Not applicable | Not yet recruiting | Centre Hospitalier Universitaire de Saint Etienne | 128 | 2026-10-01 | 2026-09-16 |
| Safety, Pharmacokinetics and Efficacy of BV100 Plus Low Dose Polymyxin B Plus Ceftazidime/Avibactam, or Plus Cefiderocol in Patients With Pulmonary and Extrapulmonary Infections Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex BV100 with 50 mg polymyxin B plus ceftazidime/avibactam, BV100 with 50 mg polymyxin B plus cefiderocol, Best Available Therapy (BAT) - Ventilator Associated Bacterial Pneumonia (VABP), Hospital Acquired Bacterial Pneumonia (HABP) | Phase 2 | Not yet recruiting | BioVersys AG | 120 | 2026-07-01 | 2026-02-24 |
| Early Discontinuation of Antibiotics in Paediatric High-risk Febrile Neutropenia Early Discontinuation of Antibiotics, Standard Antibiotic Continuation Strategy - Febrile Neutropenia (FN), Pediatric Cancer | Phase 4 | Not yet recruiting | Hospital Universitari Vall d'Hebron Research Institute | 136 | 2026-06-01 | 2026-05-15 |
| Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies Ceftazidime, Ciprofloxacin - Neutropenic Fever, Acute Lymphoblastic Leukemia | Phase 4 | Recruiting | Gadjah Mada University | 120 | 2025-06-01 | 2025-08-22 |
| Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing Beta-lactam antibiotic (cefazolin, cefuroxime, cefotaxime, ceftazidime, ceftriaxone, cefepime, pre-pen, penicillin G, ampicillin, and histamine) double-blind skin testing, Culprit cephalosporin (cefazolin, ceftazidime, ceftriaxone, cefepime, cephalexin, cefaclor, cefadroxil, cefuroxime, cefpodoxime, cefdinir, or cefixime) double-blind placebo-controlled drug challenge, Similar cephalosporin (cefepime, ceftriaxone, cefaclor, cephalexin, cefixime, or cefdinir) antibiotic double-blind placebo-controlled drug challenge - Drug Allergy, Cephalosporin Allergy | Phase 2 | Recruiting | Massachusetts General Hospital | 300 | 2025-05-05 | 2026-09-04 |
| Comparing Oral Versus Parenteral Antimicrobial Therapy Amoxicillin, amoxicillin-clavulanate, cefadroxil, cefpodoxime, cefalexin, ciprofloxacin, delafloxacin, doxycycline, levofloxacin, linezolid, Ampicillin, ampicillin-sulbactam, cefazolin, cefepime, ceftaroline, ceftazidime, ceftazidime-avibactam, dalbavancin, daptomycin, ertapenem - Endovascular Infection, Bone and Joint Infection | Phase 4 | Terminated | West Virginia University | 94 | 2023-08-04 | 2025-08-26 |
| Oral ARV-1801 Given in Combination With Intravenous Ceftazidime or Meropenem for Treatment of Melioidosis in Hospitalized Patients Ceftazidime or meropenem, ARV-1801, Placebo - Melioidosis | Phase 2 | Completed | Arrevus Inc. | 125 | 2022-06-14 | 2024-02-16 |
| The Antibiogram and Outcomes of Antimicrobial Regimens in Microbial Keratitis: A Prospective Cohort Study Moxifloxacin Ophthalmic 0.5% Ophthalmic Solution, Ceftazidime 5% + vancomycin 5%, Gentamicin 1.4% + vancomycin 5% - Bacterial Keratitis, Fungal Keratitis | Completed | Alexandria University | 123 | 2021-12-31 | 2024-01-25 | |
| Early Versus Late Stopping of Antibiotics in Children With Cancer and High-risk Febrile Neutropenia Piperacillin and Tazobactam for Injection, Cefepime Injection, Ceftazidime Injection - Febrile Neutropenia | Phase 4 | Completed | Murdoch Childrens Research Institute | 55 | 2021-11-15 | 2026-03-20 |
| Antibiotic Plasma Concentrations During Continuous Renal Replacement Therapy With a High Adsorption Membrane (oXiris®) Continuous venovenous hemodiafiltration with high adsorption membrane (oXiris®), Antibiotics - Hemodiafiltration, Sepsis | Completed | Hospital Universitari de Bellvitge | 20 | 2021-01-01 | 2023-10-10 | |
| Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care: - Coronavirus Infection (COVID-19), Pulmonary Arterial Hypertension | Recruiting | Duke University | 5000 | 2020-03-05 | 2026-08-21 | |
| Combination Antibiotic Therapy Compared to Monotherapy in the Treatment of Acute COPD Beta-Lactams, Fluoroquinolone - COPD Exacerbation Acute | Phase 2 / Phase 3 | Completed | Haiphong University of Medicine and Pharmacy | 170 | 2020-01-01 | 2021-05-10 |
| Is Cefazolin, Ceftazidime and Ciprofloxacin Dosing Optimal in Hemodialysis Patients? Cefazolin, Ceftazidime - Hemodialysis Complication, Infectious Disease | Completed | University of Manitoba | 40 | 2019-10-18 | 2024-05-16 | |
| Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever Ceftazidime Injection, Cefepime Injection - Neutropenia, Febrile, Leukemia | Phase 4 | Completed | Universitas Indonesia | 72 | 2019-03-01 | 2019-12-06 |
| A Study the Population Pharmacokinetics of Children of Infectious Disease in Central Nervous System Children with the usage of anti-infective drugs - Central Nervous System Infection | Unknown | Wei Zhao | 800 | 2019-01-01 | 2019-05-23 | |
| Antibiotic Therapy vs Laparscopic Appendectomy in Pediatric Chronic Appendicitis Ceftazidime, appendectomy - Chronic Appendicitis | Not applicable | Unknown | Zunyi Medical College | 200 | 2019-01-01 | 2018-11-28 |
| Phase 1 Study to Evaluate DDI, PK, Safety, Tolerability of SPR741 SPR741, Ceftazidime, Piperacillin/tazobactam - Healthy Volunteers | Phase 1 | Completed | Spero Therapeutics | 27 | 2017-11-10 | 2018-01-05 |
| Single- Versus Multiple-dose Antimicrobial Prophylaxis for The Prevention of Infectious Complications Associated With Peroral Endoscopic Myotomy(POEM) for Achalasia Saline Solution, Ceftazidime - Esophageal Achalasia | Phase 2 / Phase 3 | Unknown | Shanghai Zhongshan Hospital | 666 | 2017-10-01 | 2018-11-07 |
| Population Pharmacokinetics of Anti-infective Drugs in Children With Infectious Diseases cephalosporins,penicillins,macrolides,carbapenems and antiviral drugs - Children; Infection | Unknown | Beijing Children's Hospital | 800 | 2017-06-21 | 2017-12-19 |
Showing 20 of 54. Sign in to see all of them.
Cystic Fibrosis (6) · Febrile Neutropenia (6) · Pneumonia (6) · Pseudomonas Infections (5) · Sepsis (4) · Infections (3) · Neoplasms (3) · Pneumonia, Ventilator-Associated (3) · Bacteremia (2) · Central Nervous System Infections (2) · Fever (2) · Hypersensitivity (2) · Melioidosis (2) · Neutropenia (2) · Acute Kidney Injury (1)
Pfizer (6) · Basilea Pharmaceutica (3) · Alexandria University (1) · Arrevus Inc. (1) · Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche (1) · Beijing Children's Hospital (1) · BioVersys AG (1) · CHU de Reims (1) · Centre Hospitalier Universitaire de Saint Etienne (1) · Children's Mercy Hospital Kansas City (1) · Chinese University of Hong Kong (1) · Chulalongkorn University (1) · Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (1) · Duke University (1) · Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1)
United States (11) · France (6) · China (5) · United Kingdom (4) · Spain (3) · Thailand (3) · Canada (2) · Germany (2) · India (2) · Indonesia (2) · Lebanon (2) · Poland (2) · Australia (1) · Belgium (1) · Bulgaria (1)
Paul Newell, MD (3) · Mirjana Kujacic, MD (2) · A-Dong Shen, Master (1) · Ahmad Haidar, MD (1) · Amira A Nayel, PharmD (1) · Annelize Koch, MBChB (1) · Arif R. Sarwari, MD, MSc, MBA (1) · Carole A Sable, MD (1) · Chi Hornik (1) · Christelle Tarbouriech, Dr (1) · Daniel J Ostlie, MD (1) · David A Khan, MD (1) · David Mathews, MD (1)
PMID 24723282, PMID 30808293, PMID 33960817, PMID 34155899, PMID 41251370, PMID 15276398, PMID 15770833, PMID 15840453, PMID 18225981, PMID 18570578, PMID 19588358, PMID 21649882, PMID 22530208, PMID 23145859, PMID 23254142, PMID 23317527, PMID 24150927, PMID 25155587, PMID 25359677, PMID 25583727, PMID 25628457, PMID 26289222, PMID 26445823, PMID 26755499, PMID 28288784, PMID 28601833, PMID 29507070, PMID 29608680, PMID 30061279, PMID 30221827, PMID 30962334, PMID 31262767, PMID 31331757, PMID 31554370, PMID 32129861, PMID 32457995, PMID 33020163, PMID 38215770, PMID 41419216, PMID 4902833, PMID 8948280
2005 (1), U01AI184071 (1)